Performant Healthcare Past Earnings Performance
Past criteria checks 0/6
Performant Healthcare has been growing earnings at an average annual rate of 33.1%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been declining at an average rate of 8.2% per year.
Key information
33.1%
Earnings growth rate
42.4%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | -8.2% |
Return on equity | -10.8% |
Net Margin | -6.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Performant Financial: In-Line Quarter And Outlook Despite Headwinds - Hold
Nov 27Performant Financial: Decent Quarter But Further Progress Required
Aug 13Getting In Cheap On Performant Financial Corporation (NASDAQ:PFMT) Might Be Difficult
Jul 30Performant Financial (NASDAQ:PFMT) Is Carrying A Fair Bit Of Debt
Jul 04Performant Financial: Slowly Progressing Towards Long-Term Targets - Hold
Jun 03Investors Aren't Entirely Convinced By Performant Financial Corporation's (NASDAQ:PFMT) Revenues
Apr 11Performant Financial: No Earnings Inflection Anytime Soon, Hold
Mar 19Is Performant Financial (NASDAQ:PFMT) Using Debt Sensibly?
Nov 09Is Performant Financial (NASDAQ:PFMT) Using Too Much Debt?
Aug 07Performant Financial Corporation (NASDAQ:PFMT) Investors Are Less Pessimistic Than Expected
Jun 08Is Performant Financial (NASDAQ:PFMT) Weighed On By Its Debt Load?
Mar 16Performant announces partnership with Priority Health
Oct 11Performant Financial: On Track To Achieve Full-Year Targets Despite Ongoing Headwinds
Sep 30Calculating The Fair Value Of Performant Financial Corporation (NASDAQ:PFMT)
Sep 16We Think Performant Financial (NASDAQ:PFMT) Has A Fair Chunk Of Debt
Aug 12Performant Financial (NASDAQ:PFMT) Has Some Difficulty Using Its Capital Effectively
Jun 14Is Performant Financial (NASDAQ:PFMT) Using Too Much Debt?
May 10Performant Financial: Good Progress On Business Model Transition Despite Headwinds
May 02Is Performant Financial (NASDAQ:PFMT) Using Too Much Debt?
Feb 02These Return Metrics Don't Make Performant Financial (NASDAQ:PFMT) Look Too Strong
Jan 11The Prognosis On Performant Financial
Nov 22A Look At The Fair Value Of Performant Financial Corporation (NASDAQ:PFMT)
Nov 16Auditing Performant's Upside
Aug 10Here's Why Performant Financial (NASDAQ:PFMT) Can Manage Its Debt Responsibly
Aug 04Performant Financial Corporation's (NASDAQ:PFMT) Intrinsic Value Is Potentially 49% Above Its Share Price
Jul 16Performant Financial to join Russell Microcap Index
Jun 08Returns on Capital Paint A Bright Future For Performant Financial (NASDAQ:PFMT)
May 09Performant Financial (NASDAQ:PFMT) Seems To Use Debt Quite Sensibly
Mar 16What Type Of Returns Would Performant Financial's(NASDAQ:PFMT) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Feb 18The 31% Return On Capital At Performant Financial (NASDAQ:PFMT) Got Our Attention
Jan 14Performant Financial receives Nasdaq non-compliance notification
Dec 31Performant Financial (NASDAQ:PFMT) Takes On Some Risk With Its Use Of Debt
Dec 10Performant Financial: Buy With Both Hands After Post-Earnings Sell-Off Provides Attractive Entry Point
Nov 16Revenue & Expenses Breakdown
How Performant Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 121 | -8 | 0 | 0 |
30 Jun 24 | 119 | -6 | 0 | 0 |
31 Mar 24 | 115 | -7 | 0 | 0 |
31 Dec 23 | 114 | -8 | 0 | 0 |
30 Sep 23 | 110 | -9 | 1 | 0 |
30 Jun 23 | 108 | -10 | 0 | 0 |
31 Mar 23 | 108 | -9 | 0 | 0 |
31 Dec 22 | 109 | -7 | 0 | 0 |
30 Sep 22 | 112 | -9 | 0 | 0 |
30 Jun 22 | 113 | -9 | 0 | 0 |
31 Mar 22 | 120 | -8 | 0 | 0 |
31 Dec 21 | 124 | -10 | 0 | 0 |
30 Sep 21 | 133 | -4 | 0 | 0 |
30 Jun 21 | 140 | 0 | 0 | 0 |
31 Mar 21 | 141 | -6 | 0 | 0 |
31 Dec 20 | 156 | -14 | 0 | 0 |
30 Sep 20 | 160 | -22 | 0 | 0 |
30 Jun 20 | 159 | -32 | 0 | 0 |
31 Mar 20 | 161 | -31 | 0 | 0 |
31 Dec 19 | 150 | -27 | 0 | 0 |
30 Sep 19 | 146 | -28 | 0 | 0 |
30 Jun 19 | 138 | -28 | 0 | 0 |
31 Mar 19 | 134 | -25 | 0 | 0 |
31 Dec 18 | 156 | -8 | 0 | 0 |
30 Sep 18 | 149 | -2 | 0 | 0 |
30 Jun 18 | 151 | -2 | 0 | 0 |
31 Mar 18 | 156 | -1 | 0 | 0 |
31 Dec 17 | 132 | -13 | 0 | 0 |
30 Sep 17 | 133 | -26 | 0 | 0 |
30 Jun 17 | 134 | -18 | 0 | 0 |
31 Mar 17 | 136 | -14 | 0 | 0 |
31 Dec 16 | 141 | -11 | 0 | 0 |
30 Sep 16 | 149 | 3 | 0 | 0 |
30 Jun 16 | 156 | 3 | 0 | 0 |
31 Mar 16 | 159 | 3 | 0 | 0 |
31 Dec 15 | 159 | -2 | 0 | 0 |
30 Sep 15 | 158 | -6 | 0 | 0 |
30 Jun 15 | 159 | -7 | 0 | 0 |
31 Mar 15 | 175 | -1 | 0 | 0 |
31 Dec 14 | 195 | 9 | 0 | 0 |
30 Sep 14 | 216 | 20 | 0 | 0 |
30 Jun 14 | 253 | 36 | 0 | 0 |
31 Mar 14 | 265 | 41 | 0 | 0 |
31 Dec 13 | 255 | 36 | 0 | 0 |
Quality Earnings: PHLT is currently unprofitable.
Growing Profit Margin: PHLT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHLT is unprofitable, but has reduced losses over the past 5 years at a rate of 33.1% per year.
Accelerating Growth: Unable to compare PHLT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PHLT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: PHLT has a negative Return on Equity (-10.82%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:51 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Performant Healthcare, Inc. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Richard Close | Avondale Partners |
Kyle Bauser | B. Riley Securities, Inc. |
Michael Tarkan | Compass Point Research & Trading, LLC |